Comparing Intubation Rates in Patients Receiving Parenteral Olanzapine With and Without a Parenteral Benzodiazepine in the Emergency Department

被引:0
|
作者
Cole, Jon B. [1 ,2 ]
Stang, Jamie L. [1 ,2 ]
Collins, Jacob D. [1 ]
Klein, Lauren R. [1 ]
Devries, Paige A. [1 ,3 ]
Smith, Jennifer [4 ]
Pepin, Lesley C. [1 ,2 ]
Fuchs, Ryan T. [1 ,2 ]
Driver, Brian E. [1 ,2 ]
机构
[1] Hennepin Healthcare, Dept Emergency Med, Minneapolis, MN 55404 USA
[2] Univ Minnesota, Med Sch, Dept Emergency Med, Minneapolis, MN 55455 USA
[3] Kansas City Univ, Coll Osteopath Med, Kansas City, MO USA
[4] Univ Minnesota, Minneapolis, MN USA
关键词
ACUTELY AGITATED PATIENT; TREATING ACUTE AGITATION; INTRAMUSCULAR OLANZAPINE; ACUTE ALCOHOL; QT PROLONGATION; DROPERIDOL; MIDAZOLAM; HALOPERIDOL; SEDATION; SAFETY;
D O I
10.1016/j.annemergmed.2024.05.006
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objective: United States prescribing information recommends against coadministration of injectable olanzapine with injectable benzodiazepines due to a risk of cardiorespiratory depression, whereas European prescribing information recommends the 2 drugs not be administered within 60 minutes of each other. In contrast, a recently published American College of Emergency Physicians clinical policy recommends injectable olanzapine and benzodiazepines be coadministered for treating severe agitation. We sought to compare injectable olanzapine with and without injectable benzodiazepines for evidence of cardiorespiratory depression. Methods: We performed a retrospective study of patients in an urban emergency department from January 2017 through November 2019 who received parenteral olanzapine with or without parenteral benzodiazepines. We included patients receiving 2 total medication doses, either olanzapine+benzodiazepine or 2 doses of olanzapine, coadministered within 60 minutes. The primary outcome was tracheal intubation in the emergency department. Secondary outcomes included hypotension (systolic blood pressure less than 90 mmHg) and hypoxemia (SpO2 less than 90%). Results: We identified 693 patients (median [alcohol]- 210 mg/dL, median age- 37 years [IQR 29 to 49]). In total, 549 received 2 doses of olanzapine, and 144 patients received olanzapine and a benzodiazepine. We found no difference in intubation rates between the olanzapine-only group (21/549, 3.8%) and the olanzapine+benzodiazepine group (5/144, 3.5%; difference- 0.3%, 95% confidence interval- 3.0% to 3.7%). Rates of hypoxemia (2% olanzapine-only and 3% olanzapine+benzodiazepine) and hypotension (9% both groups) also were not different between groups. Conclusion: We found no difference in cardiorespiratory depression between patients receiving only olanzapine versus olanzapine plus a benzodiazepine. [Ann Emerg Med. 2024;84:658-667.]
引用
收藏
页码:658 / 667
页数:10
相关论文
共 25 条
  • [21] Comparing Expert and Non-Expert Assessment of Patients Presenting with Neurological Symptoms to the Emergency Department: A Retrospective Observational Study
    Hoyer, Carolin
    Stein, Patrick
    Ebert, Anne
    Rausch, Hans-Werner
    Nagel, Simon
    Eisele, Philipp
    Alonso, Angelika
    Platten, Michael
    Szabo, Kristina
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2020, 16 : 447 - 456
  • [22] A cost minimisation analysis comparing oral linezolid and intravenous daptomycin administered via an outpatient parenteral antibiotic therapy programme in patients requiring prolonged antibiotic courses
    Faller, E.
    Jackson, A.
    JOURNAL OF CHEMOTHERAPY, 2023, 35 (05) : 411 - 424
  • [23] A Prospective Cohort Study Comparing Long-Term Outcomes with and without Palifermin in Patients Receiving Hematopoietic Cell Transplantation for Hematologic Malignancies
    Saber, Wael
    Steinert, Patricia
    Zhang, Mei-Jie
    Chen, Min
    Pope, Andrea
    Keating, Armand
    Wingard, John R.
    Ballen, Karen
    Stiff, Patrick
    Perales, Miguel-Angel
    Forman, Stephen
    Champlin, Richard
    Langston, Amelia
    Rudebeck, Mattias
    Horowitz, Mary
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (10): : 837.e1 - 837.e10
  • [24] Comparing Factor Use and Bleed Rates in US Hemophilia A Patients Receiving Prophylaxis with 3 Different Long-Acting Recombinant Factor VIII Products
    Simpson, Mindy L.
    Desai, Vidhi
    Maro, Geraldine S.
    Yan, Songkai
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020, 26 (04): : 504 - 512
  • [25] Randomized Clinical Trial Comparing a Patient-Driven Titration Protocol of Intravenous Hydromorphone With Traditional Physician-Driven Management of Emergency Department Patients With Acute Severe Pain
    Chang, Andrew K.
    Bijur, Polly E.
    Davitt, Michelle
    Gallagher, E. John
    ANNALS OF EMERGENCY MEDICINE, 2009, 54 (04) : 561 - 567